Embryo Screening and Eugenics
Embryo Screening and Eugenics
Embryo screening allows embryos created through in vitro fertilization to be examined for genetic or chromosomal characteristics before transfer to the uterus. Established forms of preimplantation genetic testing can help families avoid transmitting certain serious inherited disorders. Newer applications seek to rank embryos according to polygenic scores associated with common diseases, intelligence, height, psychiatric conditions, and other complex characteristics.
The expansion from testing for severe single-gene disorders to selecting embryos according to probabilistic predictions has revived debates about eugenics. Supporters emphasize reproductive autonomy and the possibility of reducing disease. Critics question the scientific reliability of the predictions and warn about disability discrimination, commercial pressure, unequal access, racial bias, and the normalization of selecting which kinds of people should be born.
Preimplantation Genetic Testing
Preimplantation genetic testing is performed during an IVF cycle. Cells are removed from an embryo and analyzed before a decision is made about which embryo or embryos to transfer. Different forms of testing serve different purposes.
Preimplantation genetic testing for monogenic conditions, known as PGT-M, is used when a family faces a known risk of transmitting a particular single-gene disorder. PGT-SR examines structural chromosomal rearrangements, while PGT-A attempts to identify embryos with abnormal numbers of chromosomes.
Even established forms of testing have limitations. Embryo biopsy, mosaic results, uncertain findings, false-positive or false-negative results, and differences among laboratories can complicate interpretation. Professional organizations therefore emphasize informed consent, genetic counseling, laboratory standards, and, in some circumstances, confirmatory prenatal testing.
Polygenic Embryo Screening
Polygenic embryo screening, frequently called PGT-P, uses polygenic scores to estimate an embryo’s probability of developing common diseases or displaying complex characteristics. These scores combine information from many genetic variants, each of which generally has a very small statistical association with the outcome being studied.
Polygenic scores estimate probabilities rather than destinies. Health, intelligence, behavior, educational attainment, and many other characteristics result from complicated interactions among genes, family circumstances, social conditions, environmental exposures, and chance.
Scores developed by comparing unrelated adults may not reliably distinguish among embryos produced by the same parents. Sibling embryos share much of their genetic inheritance, limiting the differences that selection can produce. The usefulness of screening also depends on the number of embryos available, the accuracy of the score, the prevalence of the condition, and the age and fertility of the prospective parents.
Selecting against one predicted risk may unintentionally affect other characteristics because many genetic variants influence more than one biological outcome. This phenomenon, known as pleiotropy, makes it difficult to define one embryo as genetically healthier or better than another.
Scientific and Clinical Limitations
Evidence supporting the routine clinical use of polygenic embryo screening remains limited. Predictions that identify statistical differences across large populations do not necessarily provide accurate forecasts for individual embryos. A lower score for a particular condition does not guarantee that the future child will avoid it, while a higher score does not mean the child will develop it.
Some professional organizations and regulators have concluded that PGT-P is not ready for routine clinical practice. Concerns include uncertain clinical benefits, insufficient evidence about health outcomes, potentially misleading marketing, psychological burdens, and the possibility that patients may discard otherwise viable embryos based on small or poorly understood differences.
The underlying genetic research also disproportionately represents people of European ancestry. Polygenic scores may be less accurate for people whose ancestry is underrepresented in genomic databases. Introducing these tools without addressing this imbalance could widen existing racial and health inequalities.
Eugenics and the History of Reproductive Control
Historical eugenics sought to improve populations by encouraging reproduction among people considered desirable and restricting it among those classified as undesirable. Eugenic programs used claims about heredity to justify forced sterilization, institutionalization, marriage restrictions, immigration exclusion, racial segregation, and other forms of reproductive control.
People with disabilities, poor people, racial and ethnic minorities, Indigenous communities, immigrants, prisoners, and institutionalized individuals were frequent targets. In Nazi Germany, eugenic and racial-hygiene theories contributed to compulsory sterilization, medical killing, racial persecution, and genocide.
Modern embryo screening generally differs from historical eugenics because decisions are often made by prospective parents rather than imposed directly by governments. Nevertheless, critics argue that markets, medical institutions, social expectations, insurance systems, and professional advice can also influence reproductive decisions. Individually voluntary choices may collectively reinforce judgments about which traits and lives are valued.
The term “new eugenics” is sometimes used to describe reproductive selection driven by consumer choice and commercial technology. The comparison remains contested. Some scholars reserve the term eugenics for coercive state programs, while others emphasize that eugenic effects can arise through private markets, inequality, medical authority, and social pressure.
Disability Rights and the Expressivist Objection
Disability-rights advocates have questioned reproductive practices that present disability only as a burden, tragedy, or medical failure. The expressivist objection holds that systematically selecting against embryos associated with disability may communicate a harmful judgment about people who currently live with those characteristics.
This argument does not necessarily deny the difficulties associated with serious medical conditions or reject reproductive autonomy. Instead, it asks whether parents receive accurate and balanced information about disabled lives, available treatments, social support, accessibility, and the experiences of disabled people and their families.
Disability advocates frequently support nondirective counseling that allows families to make informed decisions without pressure. They also argue that society should address discrimination and inadequate support rather than treating the prevention of disabled births as the principal response to disability.
Embryo selection can also raise questions when parents seek a child who shares a characteristic, such as deafness. These cases create conflicts among parental autonomy, cultural identity, the welfare of the future child, and the responsibilities of fertility clinics.
Reproductive Autonomy and Parental Choice
Supporters of embryo screening often argue that prospective parents should be free to use available genetic information when deciding how to form a family. If screening can reduce the likelihood of serious illness, parents may view it as an extension of preventive medicine and responsible reproductive planning.
Some philosophers defend a principle of procreative beneficence, according to which parents have moral reasons to select the embryo expected to have the best life. Critics respond that predictions about the best possible life are uncertain and shaped by contested social assumptions about health, intelligence, disability, success, and normality.
Parental choice may also affect the future child’s autonomy. Selecting traits according to parental preferences can turn children into projects of design and place expectations upon them before birth. Genetic predictions cannot guarantee that a child will develop the anticipated abilities, personality, appearance, or life path.
Meaningful reproductive autonomy requires more than the formal availability of choices. Patients need understandable information, freedom from coercion, access to qualified counseling, protection of genetic privacy, and the ability to accept or decline testing without judgment.
Reproductive Justice and Stratified Reproduction
Reproductive justice includes the right to have children, the right not to have children, and the right to raise families in safe and supportive communities. This framework evaluates embryo screening within broader histories of forced sterilization, racial discrimination, disability oppression, unequal medical treatment, and restrictions on marginalized people’s reproductive lives.
Advanced fertility treatments are expensive and often available primarily to affluent families. Polygenic embryo screening could give wealthy consumers greater access to reproductive choices while other communities continue to face inadequate health care, infertility treatment, prenatal care, and family support.
This imbalance may produce stratified reproduction, in which some people are encouraged and assisted to reproduce while others are discouraged, monitored, criminalized, or denied support. Commercial embryo selection could therefore expand individual choice for privileged groups without producing reproductive freedom or equality for society as a whole.
Global fertility markets add further complications. Differences in national laws, medical costs, citizenship, race, and economic power shape reproductive travel and relationships among intended parents, clinics, donors, laboratory workers, and surrogates.
Race, Ancestry, and Genetic Inequality
Race is a social and political classification rather than a simple biological division of humanity. Genetic ancestry and population history can be relevant to medical research, but they should not be treated as proof that socially defined races are biologically distinct or naturally unequal.
Polygenic predictions may reproduce racial inequality when researchers use unrepresentative datasets or treat race as a biological essence. Scores trained primarily on European-ancestry populations frequently perform less accurately in other populations. Unequal accuracy could cause patients to receive different levels of information or benefit according to ancestry.
The history of scientific racism demonstrates how claims about heredity can be used to portray inequality as natural and unavoidable. Responsible embryo-screening policy must therefore distinguish legitimate genetic research from racial classification, recognize the effects of racism and environmental inequality, and improve diversity in genomic studies.
Enhancement and Designer Babies
The phrase “designer babies” refers to the possibility that parents could select or modify embryos according to preferred characteristics. Although current technology cannot reliably design a child, commercial services increasingly advertise predictions involving intelligence, height, disease risk, appearance, and other traits.
The boundary between therapy and enhancement is difficult to define. Avoiding a severe childhood disorder may appear different from selecting for height or educational potential, but many characteristics exist along a spectrum. Definitions of disease, disability, normality, and improvement are influenced by cultural values and social conditions.
Critics fear that enhancement markets could intensify competition among parents, encourage unrealistic expectations, and make optional technologies feel obligatory. If genetic selection becomes normalized, parents who decline it may be blamed for the health or characteristics of their children.
Supporters contend that carefully regulated enhancement might increase well-being without repeating coercive eugenics. Whether that outcome is possible depends on scientific accuracy, equitable access, protection against discrimination, respect for future people, and meaningful democratic oversight.
Sex Selection and Savior Siblings
Embryo testing can be used for purposes beyond disease prevention. Sex selection for nonmedical reasons raises concerns about gender discrimination, family balancing, cultural preferences, and the unequal valuation of girls and boys.
Preimplantation tissue typing may be used to conceive a child whose cells can help treat a seriously ill sibling. These “savior sibling” cases raise questions about parental motives and whether the new child is valued as an individual rather than primarily as a medical resource.
Supporters argue that a child may be conceived partly to help a sibling while still being loved and respected as a full member of the family. Ethical evaluation therefore considers the welfare of both children, the medical risks involved, the limits of parental consent, and the availability of alternative treatments.
Genetic Counseling and Informed Consent
Genetic counseling plays an important role in helping patients understand the capabilities and limitations of embryo screening. Counseling should explain uncertainty, residual risk, mosaicism, pleiotropy, ancestry-related accuracy, possible incidental findings, and the difference between population-level associations and individual predictions.
Nondirective counseling seeks to support patients without steering them toward socially preferred outcomes. Counselors must recognize the eugenic history of genetics and avoid presenting one reproductive decision as automatically responsible, healthy, or morally superior.
Informed consent is especially difficult when commercial claims exceed the available evidence. Patients should know whether a test has demonstrated clinical utility, how predictions were developed, which populations were represented, what alternatives exist, and how genetic data will be stored and used.
Regulation and Commercialization
Regulation of embryo screening varies considerably among countries. The United Kingdom uses a licensing system that controls fertility clinics, embryo research, and approved uses of genetic testing. The United States relies more heavily on professional guidance, laboratory regulation, clinic policies, and consumer choice.
Rapid commercialization can allow services to reach patients before questions about accuracy, safety, fairness, and social consequences have been resolved. Advertising may describe probabilistic scores as though they can identify the healthiest, smartest, or best embryo.
Effective governance could include standards for evidence, independent review of marketing claims, laboratory-quality requirements, genetic-data protections, professional counseling, long-term outcome research, and restrictions on unsupported applications. International cooperation is also important because patients and companies can cross national borders to avoid domestic limits.
Regulation should involve patients, fertility specialists, geneticists, disability advocates, ethicists, affected communities, and the broader public. Decisions about future generations should not be left solely to commercial companies, individual clinics, or technical experts.
Embryo Screening and Genome Editing
Embryo screening selects among existing embryos, whereas germline genome editing attempts to alter inherited DNA. The two technologies are scientifically distinct but raise overlapping concerns about safety, enhancement, inequality, future generations, and human genetic design.
The birth of genetically edited children in China demonstrated the dangers of premature reproductive experimentation. The episode involved inadequate medical justification, uncertain risks, failures of consent and transparency, and insufficient oversight.
International scientific and bioethical organizations have called for strong governance before heritable genome editing is used to establish pregnancies. Even if technical risks are reduced, questions about discrimination, social division, democratic legitimacy, and responsibility toward future people would remain.
Public Understanding and Cultural Representations
Films, books, journalism, and public debate strongly influence how embryo screening is understood. Works such as Gattaca portray societies in which genetic predictions determine education, employment, relationships, and social status. Such stories illustrate how probabilistic information could become a basis for discrimination.
Public discussion sometimes exaggerates both the power and immediacy of reproductive genetics. Current science cannot precisely predict or manufacture a child’s intelligence, personality, appearance, or future success. At the same time, overstating the technology’s limitations can obscure the real ethical consequences of decisions already being offered in fertility markets.
Accurate public communication should distinguish among established medical testing, experimental polygenic screening, genetic enhancement, and genome editing. It should also explain that ethical concerns arise not only from what a technology can accomplish, but from the values, markets, and institutions surrounding its use.
Conclusion
Embryo screening can help some families reduce the risk of transmitting serious genetic conditions, but its expansion into polygenic prediction and nonmedical trait selection raises difficult scientific and social questions. Current polygenic scores offer probabilities rather than reliable forecasts, and their usefulness may be limited by small differences among sibling embryos, pleiotropy, ancestry bias, environmental influences, and uncertain clinical outcomes.
The debate cannot be reduced to a simple choice between technological progress and opposition to genetics. It involves reproductive autonomy, disability equality, racial justice, medical responsibility, commercial power, informed consent, and society’s obligations to future generations.
Avoiding a return to eugenic thinking requires attention to both coercive government policies and subtler pressures created by markets, inequality, professional authority, and cultural ideas about normality. Responsible policy should protect individual choice while ensuring accurate evidence, balanced counseling, equitable access, disability inclusion, genetic privacy, and democratic oversight.
Current Polygenic Embryo Screening Debate
Precautions for Polygenic Embryo Selection: Prohibition or Regulation?
| Tetsuya Ishii | Frontiers in Reproductive Health | 2026
Examines whether governments should prohibit or regulate embryo selection based on polygenic scores, emphasizing uncertain predictions, social inequality, parental pressure, and eugenic applications.
PGT-P Is Not Lawful in the UK and Is Not Supported by Evidence
| Human Fertilisation and Embryology Authority | HFEA | 2026
Explains why British regulators consider polygenic embryo screening scientifically unproven, ethically troubling, and potentially harmful to patients’ chances of having a baby.
Justifying Preimplantation Polygenic Embryo Screening
| Robert Resta | The DNA Exchange | 2026
Questions attempts to justify screening embryos for intelligence, height, appearance, and other traits through appeals to reproductive autonomy.
UK IVF Couples Use Legal Loophole to Rank Embryos
| Hannah Devlin | The Guardian | 2025
Reports that some British IVF patients obtained embryo data for overseas ranking by predicted intelligence, height, and health despite UK restrictions.
What Is Polygenic Embryo Screening in IVF, and Does It Work?
| Hannah Devlin | The Guardian | 2025
Explains how polygenic embryo scores are calculated and why scientists question their accuracy for predicting complex traits within families.
Polygenic Embryo Screening Is Not Ready for Clinical Use
| American Society for Reproductive Medicine | ASRM | 2025
Summarizes an expert assessment finding that polygenic embryo screening lacks demonstrated clinical utility and presents unresolved scientific and ethical concerns.
Eugenics and Polygenic Embryo Screening
| Daniel Barlevy et al. | Genetics in Medicine | 2025
Investigates how members of the public, fertility specialists, and IVF patients connect embryo screening for diseases or traits with eugenics.
Polygenic Risk Scores and Embryonic Screening
| Christopher M. Haining et al. | Journal of Medical Ethics | 2025
Reviews the ethical and regulatory problems associated with applying population-based polygenic risk scores to the selection of embryos.
Fertility Startup’s “Great Genes” Campaign Sparks Debate
| Alex Mitchell | New York Post | 2025
Describes criticism of advertising that promotes embryo ranking by intelligence, height, and disease risk as consumer choice and genetic optimization.
The Ethics of Embryo Selection
| Jonathan Anomaly | Philosophy, Politics and Economics | 2025
Considers moral arguments for and against selecting embryos by genetic predictions, including inequality, discrimination, stigma, and parental responsibility.
Scientific Evidence and Clinical Limitations
Screening Embryos for Polygenic Disease Risk: A Review
| Antonio Capalbo et al. | Human Reproduction Update | 2024
Reviews the possible clinical value and substantial limitations of selecting embryos according to predicted risks for common polygenic diseases.
Perspectives of Preimplantation Genetic Testing Patients
| Marianne Siermann et al. | Reproductive BioMedicine Online | 2024
Presents patients’ views on embryo screening, reproductive choice, psychological burdens, social pressure, and the possible expansion from disease prevention to enhancement.
Socio-Ethical Considerations of Polygenic Embryo Screening
| Marianne Siermann et al. | Social Science & Medicine | 2024
Identifies concerns about parental responsibility, the future child’s autonomy, medical uncertainty, commercialization, and pressure to select genetically preferred embryos.
Designer Babies? Ethical and Regulatory Implications
| Sonia Suter and Vardit Ravitsky | Bill of Health | 2024
Discusses how weak US regulation could permit commercial embryo ranking before the technology’s validity, fairness, and social consequences are resolved.
Embryo Screening and the New Eugenics
| Xavier Symons | Public Discourse | 2024
Argues that selecting embryos against disability or for preferred traits can revive eugenic judgments about which human lives deserve to exist.
US Startup Charging Couples to Screen Embryos for IQ
| Hannah Devlin | The Guardian | 2024
Investigates a company using genetic data to rank embryos for predicted intelligence and other traits, prompting criticism about validity, wealth, and eugenics.
Polygenic Embryo Testing: Understated Ethics, Unclear Utility
| Josephine Johnston and Lucas Matthews | Nature Medicine | 2022
Warns that uncertain clinical benefits, misleading marketing, discarded embryos, and inequitable access receive too little attention in commercial discussions.
Polygenic Scores in Biomedical Research
| Iftikhar Kullo et al. | Nature Reviews Genetics | 2022
Explains the construction, limitations, ancestry biases, and uncertain clinical usefulness of polygenic scores that may be applied to embryo selection.
Testing Embryos for IQ
| Michelle de Souza | Law, Technology and Humans | 2022
Analyzes scientific uncertainty and legal and ethical concerns surrounding attempts to rank embryos according to predicted intelligence.
Screening Embryos for Polygenic Conditions and Traits
| Gabriel Lázaro-Muñoz et al. | Genetics in Medicine | 2021
Examines the limited predictive power, pleiotropy, ancestry disparities, parental expectations, social inequality, and eugenic implications of polygenic embryo screening.
Ethics, Law, and Public Policy
Polygenic Embryo Screening: Ethical and Legal Considerations
| S. Soni and Julian Savulescu | Hastings Center Bioethics Forum | 2021
Weighs possible health benefits against concerns about enhancement, designer children, inequality, regulation, and renewed forms of eugenics.
Future Perfect: Possible Children, Science and Ethics
Explores why avoiding severe inherited disease may be ethically distinguishable from selecting children according to socially preferred characteristics.
Preimplantation Genetic Testing
| American College of Obstetricians and Gynecologists | ACOG | 2020
Describes the principal forms of preimplantation testing and cautions that test limitations and false or uncertain findings must be explained to patients.
Joint Statement on Heritable Human Genome Editing
| Nuffield Council on Bioethics et al. | Nuffield Council on Bioethics | 2020
Calls for effective public regulation and international ethical deliberation before inherited genetic interventions are introduced into reproduction.
Polygenic Risk Scores: From Research Tools to Clinical Instruments
| National Human Genome Research Institute | Genome.gov | 2020
Explains that polygenic scores estimate probabilities rather than destinies and may perform differently across ancestral populations.
Overview of Preimplantation Genetic Diagnosis
| Joe Leigh Simpson | International Journal of Gynecology & Obstetrics | 2019
Reviews the development of preimplantation diagnosis, its established medical applications, and its movement toward wider genomic testing.
A Genome Editing Year
| Peter Mills | Nuffield Council on Bioethics | 2019
Reviews debates about reproductive genome editing and stresses protecting future people, preventing injustice, and conducting broad public deliberation.
Human Genome Editing: Science, Ethics, and Governance
| National Academies of Sciences, Engineering, and Medicine | National Academies Press | 2017
Establishes scientific and ethical criteria for considering inherited genome editing while rejecting applications lacking safety, oversight, or compelling justification.
Genome Editing: An Ethical Review
| Nuffield Council on Bioethics | Nuffield Council on Bioethics | 2016
Surveys potential uses of genome editing and examines human welfare, justice, public values, inherited changes, and the risk of socially coercive applications.
Human Gene Editing: Scientific, Medical and Ethical Considerations
| National Academies | Human Gene Editing Initiative | 2015
Provides scientific and public-policy resources concerning somatic editing, embryo research, germline modification, governance, and social responsibility.
Disability Rights and Reproductive Justice
Disability Rights Critique of Prenatal Genetic Testing
| Stanford Encyclopedia of Philosophy | Stanford University | 2023
Reviews philosophical debates over disability, health, discrimination, and the assumptions used when reproductive technologies classify lives as preferable or undesirable.
Prenatal Testing and Disability Rights
| National Down Syndrome Congress | NDSC | 2023
Advocates accurate, balanced information so that genetic testing does not reinforce stereotypes or pressure families toward a particular reproductive decision.
Disability, Health, Law, and Bioethics
| I. Glenn Cohen et al., editors | Cambridge University Press | 2020
Examines how medicine, law, and bioethics can marginalize disabled people, including through genetic screening and reproductive decision-making.
Prenatal Testing and the Future of Down Syndrome
| Sarah Zhang | The Atlantic | 2020
Examines how widespread screening and selective reproduction have reduced Down syndrome births in some countries and affected families and disability communities.
The Expressivist Objection to Prenatal Testing
| Stanford Encyclopedia of Philosophy | Stanford University | 2020
Provides philosophical context for arguments that selecting against a trait may express a harmful judgment about people who already possess that trait.
Disability Equality and Prenatal Testing
| The Hastings Center | Hastings Bioethics Briefings | 2018
Introduces conflicts among reproductive autonomy, disability equality, informed consent, medical counseling, and societal efforts to prevent disability.
A Disability Rights Analysis of Genetic Selection
| Center for Genetics and Society | Biopolitical Times | 2015
Argues that genetic selection must be assessed in relation to ableism, social support, access to care, and the historical devaluation of disabled people.
The Disability Rights Critique of Prenatal Genetic Testing
| Erik Parens and Adrienne Asch | AMA Journal of Ethics | 2008
Explains the argument that selecting against disability can communicate that disabled people and their families are less valuable.
Choosing Disability in a Child
| Robert L. Klitzman | AMA Journal of Ethics | 2003
Considers ethical disputes that arise when prospective parents use reproductive technology to select for, rather than against, a disabling characteristic.
Prenatal Diagnosis and the Disability Rights Critique
| Marsha Saxton | Hastings Center Report | 2000
Presents a disability-rights argument that reproductive testing operates within a culture that often misunderstands disability and undervalues disabled lives.
Historical Eugenics and Modern Reproduction
Eugenics: Its Origin and Development
| Encyclopaedia Britannica | Britannica | 2024
Summarizes the rise of eugenics, its reliance on selective reproduction, and its influence on sterilization laws and Nazi racial policy.
Eugenics Archive
| Living Archives on Eugenics in Western Canada | University of Alberta | 2024
Provides historical records, survivor accounts, and educational material connecting eugenic ideology with disability discrimination and forced sterilization.
Eugenics in the United States
| National Human Genome Research Institute | Genome.gov | 2023
Presents a timeline showing how genetics, public policy, institutionalization, immigration restriction, and forced sterilization became intertwined.
Deadly Medicine: Creating the Master Race
| United States Holocaust Memorial Museum | Holocaust Encyclopedia | 2023
Explains how physicians and geneticists helped transform eugenic theories into compulsory sterilization, racial persecution, and mass murder.
Eugenics and Scientific Racism
| National Human Genome Research Institute | Genome.gov | 2022
Traces how hereditarian theories were used to rank human groups and justify sterilization, exclusion, racism, and other coercive policies.
Eugenics and Involuntary Sterilization: 1907–2015
| Lutz Kaelber | University of Vermont | 2015
Maps American sterilization laws and institutions, documenting the scale and geographic reach of state eugenics programs.
Eugenics: Compulsory Sterilization in 50 American States
| Living Archives on Eugenics | University of Alberta | 2013
Explains how eugenic ideas translated into laws authorizing sterilization of people labeled disabled, dependent, criminal, or socially unfit.
Eugenics and the Welfare State
| Gunnar Broberg and Nils Roll-Hansen, editors | Michigan State University Press | 2005
Demonstrates that eugenic reproductive policies appeared across different political systems and were not confined to Nazi Germany.
The Horrifying American Roots of Nazi Eugenics
| Edwin Black | History News Network | 2003
Documents links between American eugenic institutions and later German programs of racial classification and reproductive control.
Eugenics and the Nazis: The California Connection
| Edwin Black | History News Network | 2003
Describes how California’s extensive sterilization program influenced international eugenics and provided precedents admired by Nazi racial hygienists.
Preimplantation Genetic Testing in Practice
Pre-Implantation Genetic Diagnosis
| UCSF Health | University of California, San Francisco | 2024
Describes how IVF embryos are tested to reduce the likelihood of transmitting serious single-gene or chromosomal conditions.
Preimplantation Genetic Testing Program
| Weill Cornell Medicine | Center for Reproductive Medicine | 2024
Explains testing for monogenic disorders, chromosome rearrangements, and aneuploidy before embryos are selected for transfer.
Pre-Implantation Genetic Testing for Aneuploidy
| Human Fertilisation and Embryology Authority | HFEA | 2023
Explains PGT-A and cautions that embryo biopsy and chromosome screening may not improve birth rates for most fertility patients.
Approved PGT-M and PTT Conditions
| Human Fertilisation and Embryology Authority | HFEA | 2023
Lists inherited conditions for which British regulators permit embryo testing and illustrates how authorities draw boundaries around acceptable selection.
Preimplantation Genetic Testing: Technical and Clinical Risks
| American Society for Reproductive Medicine | ASRM Practice Guidance | 2023
Collects professional guidance addressing embryo testing, informed consent, test limitations, laboratory standards, and appropriate clinical use.
Preimplantation Genetic Testing: ACOG Committee Opinion
| American College of Obstetricians and Gynecologists | Obstetrics & Gynecology | 2020
Advises clinicians to explain test accuracy, mosaicism, false findings, and the possibility that prenatal testing may still be necessary.
ESHRE Good Practice Recommendations for PGT
| ESHRE PGT Consortium | Human Reproduction Open | 2020
Establishes professional recommendations for organizing and conducting preimplantation genetic testing while protecting patients and laboratory quality.
Preimplantation Genetic Testing: Indications and Controversies
| Amber R. Cooper and Emily S. Jungheim | Clinical Laboratory Medicine | 2010
Reviews embryo testing for chromosomal abnormalities, single-gene conditions, mitochondrial disease, sex selection, and tissue matching.
Embryo Screening and the Ethics of Human Genetic Engineering
| Robert Klitzman | Nature Education | 2010
Explains how embryo diagnosis may expand from avoiding severe diseases to selecting preferred characteristics and engineering human heredity.
Preimplantation Genetic Diagnosis
| Faith Lagay | AMA Journal of Ethics | 2001
Introduces PGD as an alternative to prenatal diagnosis while recognizing ethical questions about embryo disposition and selecting future children.
Enhancement, Designer Babies, and Parental Choice
The Case Against Perfection
| Michael J. Sandel | Harvard University Press | 2007
Criticizes genetic enhancement for transforming children into projects of parental design and weakening openness to unchosen human qualities.
Babies by Design
| Ronald M. Green | Yale University Press | 2007
Examines the prospects of genetically selecting or modifying children and proposes ethical boundaries for reproductive technologies.
Procreative Beneficence and Disability
| Julian Savulescu and Guy Kahane | Journal of Medical Ethics | 2005
Develops an influential defense of embryo selection while generating debate about ableism, prediction, parental duties, and eugenic reasoning.
In Defense of Posthuman Dignity
| Nick Bostrom | Bioethics | 2005
Argues that genetic enhancement need not destroy human dignity, offering a position opposed by critics concerned about hierarchy and eugenics.
Against Genetic Disenhancement
| John Harris | Journal of Medical Ethics | 2005
Argues that intentionally selecting disabling traits presents ethical issues distinct from permitting reproductive choice or preventing disease.
Better Than Well
| Carl Elliott | Harvard University Press | 2003
Explores how enhancement technologies and consumer culture reshape identity, normality, medical demand, and expectations placed upon individuals.
Procreative Beneficence: Why We Should Select the Best Children
| Julian Savulescu | Bioethics | 2001
Advances the controversial claim that parents may have moral reasons to select the embryo expected to have the best life.
From Chance to Choice
| Allen Buchanan et al. | Cambridge University Press | 2000
Provides a major philosophical analysis of genetic intervention, distributive justice, disability, enhancement, and the legacy of eugenics.
The Wisdom of Repugnance
| Leon R. Kass | The New Republic | 1997
Presents a prominent conservative objection to cloning and genetic design based on dignity, commodification, parental control, and human limits.
The Child’s Right to an Open Future
| Joel Feinberg | Freedom and Fulfillment | 1980
Supplies an influential framework for asking whether parental genetic choices improperly constrain the autonomy of future children.
Race, Inequality, and Genetic Prediction
Use of Race, Ethnicity, and Ancestry in Genomics Research
| National Academies | National Academies Press | 2023
Recommends replacing careless racial classification with scientifically justified population descriptions and attention to racism and environmental inequality.
Polygenic Risk Scores and the Social Construction of Race
| Anna C. F. Lewis and A. Cecile J. W. Janssens | New England Journal of Medicine | 2021
Warns that genetic risk tools can reproduce racial categories and disparities when social and ancestral differences are treated as biological essences.
The Genetic Lottery
| Kathryn Paige Harden | Princeton University Press | 2021
Argues that genetic differences should motivate egalitarian policies rather than claims that social inequality is natural or deserved.
Clinical Use of Polygenic Risk Scores May Exacerbate Health Disparities
| Alicia R. Martin et al. | Nature Genetics | 2019
Shows that polygenic predictions commonly perform less accurately for populations underrepresented in genomic research, potentially widening inequality.
The Missing Diversity in Human Genetic Studies
| Giorgio Sirugo, Scott Williams, and Sarah Tishkoff | Cell | 2019
Documents the overrepresentation of European ancestry in genetic research and explains why resulting predictions may not transfer across populations.
Race After Technology
| Ruha Benjamin | Polity | 2019
Shows how apparently neutral technologies can encode social bias, normalize discrimination, and create what Benjamin calls a “New Jim Code.”
Superior: The Return of Race Science
| Angela Saini | Beacon Press | 2019
Investigates the persistence of racial hereditarianism and its reappearance in contemporary genetics, medicine, and political movements.
The Social Life of DNA
| Alondra Nelson | Beacon Press | 2016
Examines how genetic ancestry technologies interact with racial identity, historical injustice, family histories, and public understandings of biology.
Misbehaving Science
| Aaron Panofsky | University of Chicago Press | 2014
Traces controversies in behavior genetics and shows how claims about inheritance, intelligence, and human difference gain scientific authority.
Fatal Invention
| Dorothy Roberts | The New Press | 2011
Critiques the revival of biological race in genomic science and connects genetic explanations with inequality and older eugenic assumptions.
Reproductive Autonomy and Counseling
Genetic Counseling and the Challenge of Eugenics
| National Society of Genetic Counselors | Genetic Counseling Cultural and Ethical Toolkit | 2023
Encourages counselors to recognize the eugenic history of genetics and avoid directing patients toward socially preferred reproductive outcomes.
Reproductive Genetic Testing: Issues and Options
| U.S. Government Accountability Office | GAO | 2020
Reviews available reproductive genetic tests, their limitations, regulatory gaps, costs, and implications for patients and health-care systems.
Ethical Issues in Genetic Testing
| World Health Organization | WHO Human Genomics | 2020
Places genetic testing within principles of consent, confidentiality, justice, counseling, cultural respect, and protection against discrimination.
Expanded Carrier Screening in Reproductive Medicine
| American College of Obstetricians and Gynecologists | ACOG | 2017
Discusses carrier screening, patient choice, informed consent, residual risk, and the need for consistent access regardless of ethnicity.
Carrier Screening in the Age of Genomic Medicine
| ACOG Committee on Genetics | Obstetrics & Gynecology | 2017
Recommends that patients receive understandable information and retain the option to decline reproductive genetic screening.
Reproductive Autonomy and the Ethics of Embryo Selection
| Stanford Encyclopedia of Philosophy | Stanford University | 2017
Surveys ethical questions involving IVF, embryo selection, reproductive liberty, disability, commercialization, parenthood, and state regulation.
The Right to Know and the Right Not to Know
| UNESCO International Bioethics Committee | UNESCO | 2015
Examines autonomy and consent in genetic testing, including rights to receive, refuse, and control sensitive genomic information.
Non-Directive Genetic Counseling
| National Society of Genetic Counselors | NCBI Bookshelf | 2010
Explains counseling principles intended to support informed reproductive decisions without coercing clients into accepting professional or social judgments.
International Declaration on Human Genetic Data
| UNESCO | United Nations Educational, Scientific and Cultural Organization | 2003
Establishes international principles for consent, privacy, nondiscrimination, data governance, and the responsible use of human genetic information.
Universal Declaration on the Human Genome and Human Rights
| UNESCO | United Nations Human Rights Office | 1997
Declares that genetic characteristics must not override human dignity or justify discrimination against individuals or groups.
Regulation and Governance
How the HFEA Regulates Fertility Treatment
| Human Fertilisation and Embryology Authority | HFEA | 2024
Explains Britain’s licensing, inspection, consent, embryo-testing, treatment, and research oversight system.
Modernising Fertility Law
| Human Fertilisation and Embryology Authority | HFEA | 2023
Considers how fertility regulation should respond to technological change while protecting patients, children, embryos, and public confidence.
Human Genome Editing: Recommendations
| World Health Organization | WHO | 2021
Proposes international governance mechanisms for human genome editing, including registries, oversight, public engagement, and action against unsafe reproductive experiments.
Human Genome Editing: A Framework for Governance
| World Health Organization | WHO | 2021
Provides a governance framework addressing safety, ethics, social justice, accountability, international coordination, and unauthorized clinical applications.
Heritable Human Genome Editing
Concludes that edited embryos should not be used to establish pregnancies until demanding scientific, medical, and societal requirements are satisfied.
Statement on Germline Genome Editing
| International Society for Stem Cell Research | ISSCR | 2019
Calls for strong oversight and condemns premature reproductive uses of embryo editing following the birth of genetically edited children in China.
Clinical Use of Human Germline Genome Editing Should Be Prohibited
| Eric Lander et al. | Nature | 2019
Calls for an international moratorium on clinical germline editing until countries establish broad public consensus and effective governance.
Statement by the Organizing Committee of the Second International Summit
| Organizing Committee | National Academies | 2018
Condemns the creation of gene-edited babies as irresponsible and emphasizes the absence of sufficient medical need, oversight, transparency, and social agreement.
Human Fertilisation and Embryology Act 2008
| Parliament of the United Kingdom | UK Legislation | 2008
Establishes legal controls over assisted reproduction, embryo testing, tissue typing, sex selection, embryo research, and heritable genetic modification.
Regulation of Preimplantation Genetic Diagnosis in the United States
| Jeffrey R. Botkin | AMA Journal of Ethics | 2003
Explains the limited US regulation of embryo testing and the resulting reliance on professional standards, clinic policies, and individual choice.
Broader Bioethical Perspectives
Eugenics, Embryo Selection, and the Equal Value Principle
| Thomas Schramme | Clinical Ethics | 2006
Evaluates whether embryo selection violates the principle that people possess equal value regardless of genetic characteristics.
Eugenic Nation
| Alexandra Minna Stern | University of California Press | 2005
Demonstrates how race, gender, immigration, disability, public health, and reproductive control shaped American eugenics.
The New Eugenics: Selective Breeding in an Era of Reproductive Technologies
| Judith Daar | University of Illinois Law Review | 2005
Examines whether individually chosen reproductive technologies collectively produce exclusionary or stratified eugenic effects.
Liberal Eugenics
| Nicholas Agar | Harvard University Press | 2004
Defends some voluntary genetic enhancement while attempting to distinguish individual reproductive choice from coercive state eugenics.
The Future of Human Nature
| Jürgen Habermas | Polity | 2003
Argues that designing inherited characteristics could undermine equality and alter the future person’s relationship to autonomy and authorship.
Redesigning Humans
| Gregory Stock | Houghton Mifflin | 2002
Predicts expanding parental use of reproductive genetics and examines the possible social transformation produced by human genetic enhancement.
Building a Better Race
| Wendy Kline | University of California Press | 2001
Examines how eugenics entered family life, women’s health, marriage counseling, sexuality, and modern reproductive practices.
Genetic Dilemmas
| Dena Davis, editor | Routledge | 2001
Brings together perspectives on reproductive testing, disability, parental choice, children’s interests, genetic counseling, and the shadow of eugenics.
In the Name of Eugenics
| Daniel J. Kevles | Harvard University Press | 1995
Provides a foundational history of eugenics and shows how efforts to control reproduction survived in altered forms after World War II.
Reproductive Technologies and the New Eugenics
| Ruth Hubbard | Issues in Reproductive and Genetic Engineering | 1987
Warns that reproductive technologies can shift eugenic control from explicit government coercion to medicine, markets, and normalized personal expectations.
Polygenic Embryo Screening and Emerging Markets
Ethical and Social Implications of Implementing Polygenic Embryo Screening
| Benjamin Cohn et al. | Genetics and Genomics Next | 2026
This scoping review identifies concerns involving uncertain benefits, inequality, disability discrimination, commercialization, informed consent, and the possible normalization of eugenic selection.
Use of Preimplantation Genetic Testing for Polygenic Disorders
| ASRM Ethics Committee | American Society for Reproductive Medicine | 2026
Concludes that current evidence does not support routine clinical use of PGT-P and warns that its expense could deepen socioeconomic disparities.
Psychiatric Genetics and Polygenic Embryo Screening
| International Society of Psychiatric Genetics | ISPG | 2025
Warns that polygenic scores cannot determine whether an embryo will develop a psychiatric condition and may influence numerous unrelated characteristics.
The Troubling Rise of Embryo Selection by Polygenic Scores
Examines commercial embryo-ranking services and concerns about weak regulation, overstated predictions, unequal access, and modern eugenics.
Screening Embryos for Disease Risk Is Not Ready for the Clinic
| Nature Editorial | Nature | 2025
Argues that embryo selection based on polygenic scores should not enter routine fertility care without stronger evidence and public oversight.
Selecting Embryos for Intelligence Raises a New Eugenics Debate
| Scientific American Staff | Scientific American | 2025
Explores the scientific weaknesses and social consequences of offering affluent families genetic predictions about intelligence and educational attainment.
Can You Really Pick the Healthiest Embryo?
| Jessica Hamzelou | MIT Technology Review | 2025
Investigates how fertility companies market probabilistic embryo rankings and why researchers dispute claims that one embryo can be identified as the healthiest.
The Business of Choosing the “Best” Embryo
Describes the growing market for embryo-scoring services and the ethical controversy surrounding consumer eugenics, disability, and genetic enhancement.
Polygenic Embryo Selection in Clinical Practice
| Multiple Authors | PubMed | 2025
Collects research evaluating whether polygenic scores can meaningfully distinguish disease risk among genetically related IVF embryos.
Preimplantation Genetic Testing for Polygenic Conditions
| European Society of Human Reproduction and Embryology | ESHRE | 2025
Provides professional guidance relevant to laboratory accuracy, patient counseling, consent, embryo biopsy, and experimental forms of genetic testing.
Scientific Accuracy and Predictive Limits
Polygenic Scores, Pleiotropy, and Embryo Selection
| Multiple Authors | PubMed | 2024
Collects studies showing that selecting embryos to reduce one predicted risk can unintentionally alter susceptibility to other diseases or traits.
The Limits of Polygenic Scores
| A. Cecile J. W. Janssens | BMJ | 2023
Explains why polygenic scores often have limited predictive value for individuals despite statistically significant population associations.
Polygenic Prediction Within Families
| Laurence J. Howe et al. | Nature Genetics | 2022
Shows that genetic predictions can perform differently within families because population-level associations may include environmental and family effects.
Within-Sibship Genome-Wide Association Studies
| Laurence J. Howe et al. | Nature Genetics | 2022
Demonstrates that conventional genetic associations may overstate direct genetic effects, complicating attempts to predict traits among sibling embryos.
Utility of Polygenic Embryo Screening for Disease Risk Reduction
| Shai Carmi et al. | Cell | 2021
Models how much disease risk might be reduced through embryo selection and finds that benefits depend heavily on family size, disease prevalence, and predictive accuracy.
Problems with Using Polygenic Scores to Select Embryos
| Todd Lencz et al. | bioRxiv | 2021
Evaluates the assumptions behind embryo ranking and emphasizes uncertainty, pleiotropy, population differences, and limited within-family prediction.
The Accuracy of Polygenic Scores in Embryo Selection
| Shai Carmi and Todd Lencz | Nature Genetics | 2021
Discusses why scores developed from unrelated adults may not produce reliable rankings among embryos from the same parents.
Polygenic Risk Prediction: Why Population Matters
| Alicia R. Martin et al. | Nature Medicine | 2021
Warns that scores trained primarily with European-ancestry data may be less accurate for other populations and could worsen health disparities.
The Unreasonable Effectiveness of the Genetic Lottery
| Alexander I. Young et al. | Nature Genetics | 2020
Investigates direct genetic effects and family-level influences that complicate predictions of complex human outcomes.
Screening Human Embryos for Polygenic Traits Has Limited Utility
| E. Karavani et al. | Cell | 2019
Demonstrates that selecting among sibling embryos produces only modest and highly uncertain predicted differences in height or intelligence.
Preimplantation Testing and IVF Outcomes
Preimplantation Genetic Testing for Aneuploidies: A Committee Opinion
| ASRM Practice Committee | American Society for Reproductive Medicine | 2024
Reviews evidence for PGT-A and finds that routine testing has not been shown to improve outcomes for every IVF patient.
Preimplantation Genetic Testing for Monogenic Conditions
| ASRM Practice Committee | American Society for Reproductive Medicine | 2023
Explains appropriate uses of PGT-M, including counseling, test development, embryo disposition, diagnostic limitations, and confirmatory prenatal testing.
Mosaic Results Following Preimplantation Genetic Testing
| ASRM Practice Committee | American Society for Reproductive Medicine | 2023
Addresses uncertain embryo classifications and the ethical and clinical difficulties involved in deciding whether mosaic embryos should be transferred.
Preimplantation Genetic Testing for Aneuploidy: The Past, Present, and Future
| Nathan R. Treff and Richard T. Scott | Fertility and Sterility | 2021
Describes changing technologies for chromosome screening and continuing controversy about their clinical usefulness.
PGT-A and Cumulative Live-Birth Rates
| J. Yan et al. | New England Journal of Medicine | 2021
Reports that conventional embryo selection was noninferior to PGT-A for cumulative live births among women with several good-quality embryos.
ESHRE Good Practice Recommendations for PGT-M
| ESHRE PGT Consortium | Human Reproduction Open | 2020
Establishes laboratory and counseling standards for testing embryos for monogenic diseases before transfer.
ESHRE Good Practice Recommendations for PGT-SR
| ESHRE PGT Consortium | Human Reproduction Open | 2020
Covers embryo testing for structural chromosome rearrangements and emphasizes validation, accuracy, reporting, and professional oversight.
Preimplantation Genetic Testing: Current Status and Future Prospects
| Dagan Wells | Reproduction | 2019
Reviews advances in embryo testing and discusses movement from diagnosing severe disorders toward broader genomic prediction.
The STAR Trial of Preimplantation Genetic Testing
| Santiago Munné et al. | Fertility and Sterility | 2019
Finds that PGT-A did not significantly improve ongoing pregnancy rates for all women undergoing IVF, illustrating the need for cautious patient claims.
Disability, Ableism, and Genetic Selection
Critiquing Ableism in Bioethics
| Multiple Authors | PubMed | 2023
Collects research examining how medical assumptions about disability can shape counseling, embryo selection, prenatal testing, and reproductive policy.
Genetic Screening and the Message About Disability
| Down Syndrome Australia | Down Syndrome Australia | 2023
Advocates nondirective counseling and balanced information so that screening does not perpetuate inaccurate assumptions about Down syndrome.
The Routledge Handbook of Disability Bioethics
| Joel Michael Reynolds and Christine Wieseler, editors | Routledge | 2022
Centers disabled scholars’ perspectives on prenatal testing, reproductive technologies, medical rationing, enhancement, and genetic selection.
Reproductive Technologies and Disability Justice
| National Partnership for Women & Families | National Partnership | 2021
Connects reproductive autonomy with disabled people’s rights to parent, receive support, avoid coercion, and make decisions free from eugenic pressure.
The Meaning of Disability in a World of Prenatal Testing
| Rosemarie Garland-Thomson | AMA Journal of Ethics | 2020
Argues that clinicians should offer realistic information about disabled lives rather than framing disability solely as tragedy or medical failure.
Disability Culture and Genetic Testing
| Disability Visibility Project | Disability Visibility Project | 2020
Presents disability-community concerns about testing practices that imply disabled people are preventable burdens rather than valued members of society.
Disability Justice and the History of Eugenics
| Sins Invalid | Disability Justice Primer | 2019
Places reproductive control within intersecting histories of ableism, racism, colonialism, poverty, gender oppression, and institutional violence.
A Disability Rights Perspective on Genetic Selection
| Disability Rights Education and Defense Fund | DREDF | 2016
Calls for balanced information, informed consent, and protection against disability discrimination in reproductive genetic services.
Disability and the New Genetics
| Multiple Authors | Routledge | 2001
Examines how emerging genetic technologies may reduce disease while simultaneously intensifying stigma against people considered genetically different.
Prenatal Testing and Disability Rights: Reassessing the Debate
| Erik Parens and Adrienne Asch | Georgetown University Press | 2000
Presents disability-rights concerns that genetic testing can reinforce misinformation and discriminatory beliefs about life with disabilities.
Reproductive Justice and Stratified Reproduction
Reproductive Justice and Genetic Technologies
| Center for Genetics and Society | CGS | 2024
Explores how commercial fertility technologies can expand choice for privileged consumers while increasing surveillance and coercion for marginalized groups.
Assisted Reproduction and Reproductive Justice
| If/When/How | If/When/How | 2024
Provides a legal and social framework for evaluating whether reproductive technologies promote genuine autonomy, equality, and family well-being.
Stratified Reproduction and Assisted Reproductive Technologies
| Multiple Authors | PubMed | 2023
Collects research on how wealth, race, nationality, gender, and citizenship determine access to assisted reproduction and genetic selection.
Policing the Womb
| Michele Goodwin | Cambridge University Press | 2020
Shows how law and medicine regulate reproduction unequally, especially for poor women and women of color.
Reproductive Justice: An Introduction
| Loretta J. Ross and Rickie Solinger | University of California Press | 2017
Defines reproductive justice as the right to have children, not have children, and raise families in safe and supportive communities.
Race, Class, and the Global Fertility Industry
| Lauren Jade Martin | University of California Press | 2017
Examines reproductive travel and how access to fertility treatment is structured by wealth, citizenship, race, and national regulation.
Transnational Reproduction
| Daisy Deomampo | Duke University Press | 2016
Studies global fertility markets and the racialized and economic inequalities connecting intended parents, clinics, donors, and surrogates.
Reproducing Race
| Khiara M. Bridges | University of California Press | 2011
Examines how medical institutions reproduce racial and class inequality through prenatal care and ideas about responsible motherhood.
The Politics of Reproductive Technologies
| Liza Mundy | University of California Press | 2007
Investigates assisted reproduction, infertility markets, embryo selection, family formation, and uneven access to fertility technologies.
Killing the Black Body
| Dorothy Roberts | Vintage Books | 1997
Connects slavery, forced sterilization, welfare policy, reproductive medicine, and genetic technologies to continuing control over Black women’s reproduction.
Eugenics, Genetics, and Medical Institutions
Pure America
| Elizabeth Catte | Belt Publishing | 2021
Documents Virginia’s eugenic institutions and challenges narratives that treat forced sterilization as distant from mainstream American history.
Eugenics: A Very Short Introduction
| Philippa Levine | Oxford University Press | 2017
Introduces the international history of efforts to improve populations through reproductive control and explains the continuing relevance of eugenic ideas.
Imbeciles: The Supreme Court, American Eugenics, and Sterilization
| Adam Cohen | Penguin Press | 2016
Reconstructs Buck v. Bell and shows how respected judges, doctors, lawyers, and reformers enabled compulsory sterilization.
War Against the Weak
| Edwin Black | Dialog Press | 2012
Documents the funding, institutions, and political networks that advanced American eugenics and influenced Nazi racial policy.
States of Delinquency
| Miroslava Chávez-García | University of California Press | 2012
Shows how racialized hereditarian ideas shaped the confinement and reproductive control of Mexican American youth in California.
The Oxford Handbook of the History of Eugenics
| Alison Bashford and Philippa Levine, editors | Oxford University Press | 2010
Surveys eugenic movements across countries and reveals their connections to medicine, colonialism, public health, race, gender, and disability.
Three Generations, No Imbeciles
| Paul A. Lombardo | Johns Hopkins University Press | 2008
Examines the people and institutions behind Buck v. Bell and the Supreme Court’s endorsement of eugenic sterilization.
Breeding Contempt
| Mark A. Largent | Rutgers University Press | 2008
Explores how scientists promoted compulsory sterilization and how eugenic policies persisted after their scientific foundations weakened.
Eugenics and the Nature–Nurture Debate
| Aaron Gillette | Palgrave Macmillan | 2007
Explores arguments about heredity and environment that shaped intelligence testing, social policy, and reproductive intervention.
Controlling Human Heredity
| Diane B. Paul | Harvard University Press | 1995
Traces the political history of hereditarian thought and shows how eugenic assumptions persisted after coercive eugenics became discredited.
Sex Selection, Savior Siblings, and Nonmedical Traits
Family Balancing and the Ethics of Embryo Selection
| Multiple Authors | PubMed | 2024
Collects research debating whether selecting an embryo’s sex for family balancing is harmless preference or a practice reinforcing gender essentialism.
Preimplantation HLA Typing and Savior Siblings
| Human Fertilisation and Embryology Authority | HFEA | 2024
Explains regulated embryo selection intended to produce a tissue-matched child who may help treat a seriously ill sibling.
Selecting for Disability: A Philosophical Debate
| Multiple Authors | PubMed | 2024
Collects arguments concerning parental autonomy, cultural identity, child welfare, disability equality, and the proper role of fertility clinics.
Use of Reproductive Technology for Sex Selection
| ASRM Ethics Committee | American Society for Reproductive Medicine | 2022
Considers autonomy, gender discrimination, clinic responsibilities, informed consent, and social consequences of selecting embryos by sex.
Conceiving a Child to Save Another
| The Hastings Center | Hastings Bioethics Briefings | 2018
Reviews embryo tissue typing, parental motives, children’s welfare, informed consent, and acceptable limits on reproductive selection.
Sex Selection for Nonmedical Reasons
| FIGO Committee for Ethical Aspects of Human Reproduction | FIGO | 2012
Opposes sex selection that reinforces discrimination and unequal social valuation of girls and boys.
Savior Siblings and the Ethics of Procreation
| Samuel Hensley | AMA Journal of Ethics | 2008
Considers whether conceiving a tissue-compatible child treats that child merely as a medical resource or can remain consistent with parental love.
The Ethics of Sex Selection
| Nuffield Council on Bioethics | Nuffield Council on Bioethics | 2002
Considers the scientific and ethical dangers of using genetic explanations and reproductive technologies to select behavioral or social characteristics.
Deaf Parents and Embryo Selection
| Julian Savulescu | Journal of Medical Ethics | 2002
Debates whether parents should be permitted to select an embryo expected to share a characteristic such as deafness.
Sex Selection and Preimplantation Genetic Testing
| Jeffrey R. Botkin | AMA Journal of Ethics | 2001
Examines whether selecting embryos for sex constitutes reproductive freedom, gender bias, consumer preference, or an inappropriate expansion of medicine.
Genetic Enhancement and Future Generations
Germline Gene Editing and the Dignity of Future Generations
| UNESCO | UNESCO Bioethics Programme | 2023
Places inherited genetic interventions within human dignity, solidarity, nondiscrimination, and responsibilities toward future generations.
CRISPR People
| Henry T. Greely | MIT Press | 2021
Analyzes the creation of genetically edited babies and proposes lessons for scientific governance, accountability, and future reproductive applications.
Editing Humanity
| Kevin Davies | Pegasus Books | 2020
Recounts the CRISPR-babies controversy and examines scientific ambition, inadequate oversight, inherited modification, and fears of designer children.
Altered Inheritance
| Françoise Baylis | Harvard University Press | 2019
Argues that decisions about inherited genome editing should involve democratic deliberation rather than scientists, companies, or prospective parents alone.
The Stronger Case for Germline Gene Editing
| John Harris | Journal of Medical Ethics | 2019
Defends carefully regulated inherited editing to prevent disease while challenging claims that every germline intervention necessarily constitutes eugenics.
Genome Editing and Human Reproduction: Social and Ethical Issues
| Nuffield Council on Bioethics | Nuffield Council on Bioethics | 2018
Concludes that reproductive genome editing might be ethically acceptable only if it protects future people and does not increase discrimination or social division.
A Crack in Creation
| Jennifer Doudna and Samuel Sternberg | Houghton Mifflin Harcourt | 2017
Explains CRISPR’s development and warns that inherited human modification could produce unintended biological and social consequences.
The Gene Machine
| Bonnie Rochman | Scientific American/Farrar, Straus and Giroux | 2017
Examines how genetic testing affects pregnancy, parental expectations, disability, medical decisions, and ideas about the perfect child.
The End of Sex and the Future of Human Reproduction
| Henry T. Greely | Harvard University Press | 2016
Predicts that reproductive cells made from stem cells could enable parents to create and genetically compare large numbers of embryos.
Genetic Enhancement and the Point of Social Equality
| Allen Buchanan et al. | Philosophy & Public Affairs | 2000
Examines whether genetic enhancement would threaten equality or whether fair institutions could prevent genetic advantages from becoming social domination.
Media, Culture, and Public Understanding
Designer Babies: Where Should We Draw the Line?
| Zaria Gorvett | BBC Future | 2019
Reviews the boundary between preventing serious disease and selecting children for enhancement, appearance, or socially valued traits.
The DIY Designer Baby Project Funded by Bitcoin
| Antonio Regalado | MIT Technology Review | 2019
Reports on attempts to develop reproductive gene-editing technology outside established institutions and regulatory systems.
The Untold Story of the “Circle of Trust” Behind the CRISPR Babies
| Antonio Regalado | MIT Technology Review | 2019
Investigates the network of researchers who knew about the embryo-editing experiment and the failures that allowed it to proceed.
How Close Are We to Designer Babies?
| Antonio Regalado | MIT Technology Review | 2018
Explains how embryo testing and genome editing could converge while emphasizing biological complexity and inadequate governance.
The CRISPR Baby Scandal Gets Worse by the Day
| Ed Yong | The Atlantic | 2018
Details failures of consent, scientific justification, transparency, risk assessment, and oversight in the creation of gene-edited children.
Chinese Scientist Claims to Have Created Gene-Edited Babies
| Marilynn Marchione | Associated Press | 2018
Reports the announcement of the first genetically edited births and the immediate international condemnation from scientists and ethicists.
The Prospect of Designer Babies
| Cary Funk et al. | Pew Research Center | 2016
Surveys public attitudes toward genetic enhancement and finds widespread concern about inequality, morality, unintended effects, and pressure to participate.
23andMe Patents a Designer-Baby System
| Daniela Hernandez | Wired | 2013
Reports on a patent for selecting reproductive donors according to predicted traits, raising concerns about commercialization and consumer eugenics.
A “Designer Baby” Clinic Abandons Cosmetic Trait Screening
Describes public opposition that led a fertility clinic to withdraw plans to offer embryo selection for hair, eye, and skin characteristics.
Gattaca and the Genetic Imaginary
| Phil Bereano | Nature Genetics | 2000
Uses the film’s genetically stratified society to consider discrimination, embryo selection, privacy, and the social meaning of genetic prediction.
